| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | metalloendopeptidase activity | OMA1 ADAM15 MMP23B ADAMTS13 ADAMTS5 MMP20 ADAM10 ADAMTS12 MMP25 MMP24 ADAMTS7 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 5.44e-25 | 120 | 123 | 21 | GO:0004222 |
| GeneOntologyMolecularFunction | metallopeptidase activity | OMA1 ADAM15 MMP23B ADAMTS13 ADAMTS5 MMP20 ADAM10 ADAMTS12 MMP25 MMP24 ADAMTS7 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 3.62e-20 | 200 | 123 | 21 | GO:0008237 |
| GeneOntologyMolecularFunction | endopeptidase activity | OMA1 ADAM15 MMP23B ADAMTS13 ADAMTS5 MMP20 ADAM10 ADAMTS12 MMP25 MMP24 ADAMTS7 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 2.01e-13 | 430 | 123 | 21 | GO:0004175 |
| GeneOntologyMolecularFunction | peptidase activity | OMA1 USP28 ADAM15 MMP23B USP24 ADAMTS13 ADAMTS5 MMP20 ADAM10 ADAMTS12 MMP25 MMP24 USP51 ADAMTS7 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 1.53e-12 | 654 | 123 | 24 | GO:0008233 |
| GeneOntologyMolecularFunction | zinc ion binding | MYCBP2 MMP23B FBXO11 ADAMTS13 ADAMTS5 MMP20 ADA2 RXRB SLC30A7 MMP25 IFIH1 MMP24 USP51 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 SOD1 | 4.74e-09 | 891 | 123 | 23 | GO:0008270 |
| GeneOntologyMolecularFunction | transition metal ion binding | MYCBP2 MMP23B FBXO11 ADAMTS13 ADAMTS5 MMP20 ADA2 RXRB SLC30A7 MMP25 IFIH1 MMP24 USP51 CYP7B1 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 SOD1 | 2.23e-07 | 1189 | 123 | 24 | GO:0046914 |
| GeneOntologyMolecularFunction | triacylglycerol lipase activity | 1.85e-05 | 26 | 123 | 4 | GO:0004806 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 2.35e-05 | 190 | 123 | 8 | GO:0004252 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 4.33e-05 | 207 | 123 | 8 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 5.12e-05 | 212 | 123 | 8 | GO:0017171 | |
| GeneOntologyMolecularFunction | metalloexopeptidase activity | 7.18e-05 | 70 | 123 | 5 | GO:0008235 | |
| GeneOntologyMolecularFunction | monoacylglycerol lipase activity | 1.20e-04 | 16 | 123 | 3 | GO:0047372 | |
| GeneOntologyMolecularFunction | mannose-ethanolamine phosphotransferase activity | 2.24e-04 | 4 | 123 | 2 | GO:0051377 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity involved in amyloid precursor protein catabolic process | 2.24e-04 | 4 | 123 | 2 | GO:1902945 | |
| GeneOntologyMolecularFunction | carboxylic ester hydrolase activity | 4.28e-04 | 157 | 123 | 6 | GO:0052689 | |
| GeneOntologyMolecularFunction | metalloaminopeptidase activity | 5.35e-04 | 26 | 123 | 3 | GO:0070006 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 5.97e-04 | 110 | 123 | 5 | GO:0008238 | |
| GeneOntologyMolecularFunction | integrin binding | 7.58e-04 | 175 | 123 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | tumor necrosis factor binding | 7.75e-04 | 7 | 123 | 2 | GO:0043120 | |
| GeneOntologyMolecularFunction | metallodipeptidase activity | 1.64e-03 | 10 | 123 | 2 | GO:0070573 | |
| GeneOntologyMolecularFunction | lipase activity | 1.65e-03 | 138 | 123 | 5 | GO:0016298 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-oxygen bonds | 2.20e-03 | 42 | 123 | 3 | GO:0016875 | |
| GeneOntologyMolecularFunction | aminoacyl-tRNA ligase activity | 2.20e-03 | 42 | 123 | 3 | GO:0004812 | |
| GeneOntologyMolecularFunction | aminopeptidase activity | 2.35e-03 | 43 | 123 | 3 | GO:0004177 | |
| GeneOntologyBiologicalProcess | collagen catabolic process | ADAM15 MMP23B MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 6.64e-20 | 53 | 123 | 14 | GO:0030574 |
| GeneOntologyBiologicalProcess | collagen metabolic process | ADAM15 MMP23B MMP20 MMP25 MMP24 RAPGEF3 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 1.21e-14 | 148 | 123 | 15 | GO:0032963 |
| GeneOntologyBiologicalProcess | extracellular matrix disassembly | ADAM15 ADAMTS5 MMP20 ADAM10 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 | 2.22e-14 | 75 | 123 | 12 | GO:0022617 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | ADAM15 MMP23B ADAMTS13 ADAMTS5 MMP20 ADAM10 ADAMTS12 MMP25 MMP24 ADAMTS7 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 1.03e-12 | 377 | 123 | 19 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | ADAM15 MMP23B ADAMTS13 ADAMTS5 MMP20 ADAM10 ADAMTS12 MMP25 MMP24 ADAMTS7 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 1.08e-12 | 378 | 123 | 19 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | ADAM15 MMP23B ADAMTS13 ADAMTS5 MMP20 ADAM10 ADAMTS12 MMP25 MMP24 ADAMTS7 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 1.14e-12 | 379 | 123 | 19 | GO:0045229 |
| GeneOntologyBiologicalProcess | protein catabolic process | OMA1 TRIB2 MYCBP2 USP28 LRRK2 HIPK2 FBXO11 ADAMTS13 MMP20 ADAM10 ADAMTS12 ADAMTS7 MMP3 ASCC3 MMP8 MMP9 MMP13 MMP14 ZNF418 TMUB2 | 9.51e-06 | 1115 | 123 | 20 | GO:0030163 |
| GeneOntologyBiologicalProcess | cellular component disassembly | ADAM15 ADAMTS5 MMP20 ADAM10 ATAD2B MMP1 MMP3 ASCC3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 | 1.91e-05 | 617 | 123 | 14 | GO:0022411 |
| GeneOntologyBiologicalProcess | cellular response to UV-A | 3.30e-05 | 11 | 123 | 3 | GO:0071492 | |
| GeneOntologyBiologicalProcess | response to UV-A | 8.94e-05 | 15 | 123 | 3 | GO:0070141 | |
| GeneOntologyBiologicalProcess | regulation of neuroinflammatory response | 1.62e-04 | 46 | 123 | 4 | GO:0150077 | |
| GeneOntologyCellularComponent | extracellular matrix | LAMB4 MMP23B ADAMTS13 ADAMTS5 MMP20 ADAM10 ZP3 ADAMTS12 MMP25 MMP24 ADAMTS7 LINGO4 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 3.30e-10 | 656 | 125 | 21 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LAMB4 MMP23B ADAMTS13 ADAMTS5 MMP20 ADAM10 ZP3 ADAMTS12 MMP25 MMP24 ADAMTS7 LINGO4 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 3.49e-10 | 658 | 125 | 21 | GO:0030312 |
| GeneOntologyCellularComponent | t-UTP complex | 1.06e-04 | 3 | 125 | 2 | GO:0034455 | |
| GeneOntologyCellularComponent | RAVE complex | 1.06e-04 | 3 | 125 | 2 | GO:0043291 | |
| GeneOntologyCellularComponent | 90S preribosome | 6.81e-04 | 29 | 125 | 3 | GO:0030686 | |
| Domain | Pept_M10_metallopeptidase | ADAM15 MMP23B ADAMTS13 MMP20 ADAM10 ADAMTS12 MMP25 MMP24 ADAMTS7 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 6.93e-31 | 43 | 124 | 19 | IPR001818 |
| Domain | CYSTEINE_SWITCH | ADAM15 MMP20 ADAM10 ADAMTS12 MMP25 MMP24 ADAMTS7 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 4.02e-27 | 41 | 124 | 17 | PS00546 |
| Domain | - | ADAM15 MMP23B ADAMTS13 ADAMTS5 MMP20 ADAM10 ADAMTS12 MMP25 MMP24 ADAMTS7 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 1.88e-26 | 81 | 124 | 20 | 3.40.390.10 |
| Domain | MetalloPept_cat_dom | ADAM15 MMP23B ADAMTS13 ADAMTS5 MMP20 ADAM10 ADAMTS12 MMP25 MMP24 ADAMTS7 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 1.88e-26 | 81 | 124 | 20 | IPR024079 |
| Domain | ZINC_PROTEASE | OMA1 ADAM15 MMP23B ADAMTS13 ADAMTS5 MMP20 ADAM10 ADAMTS12 MMP25 MMP24 ADAMTS7 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 2.61e-26 | 98 | 124 | 21 | PS00142 |
| Domain | Peptidase_M10 | MMP23B ADAMTS13 MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 2.81e-25 | 24 | 124 | 14 | PF00413 |
| Domain | M10A_MMP | MMP23B MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 2.76e-23 | 23 | 124 | 13 | IPR033739 |
| Domain | Pept_M10A | MMP23B MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 2.76e-23 | 23 | 124 | 13 | IPR021190 |
| Domain | PG_binding_1 | MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 5.12e-22 | 20 | 124 | 12 | PF01471 |
| Domain | Peptidoglycan-bd-like | MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 5.12e-22 | 20 | 124 | 12 | IPR002477 |
| Domain | Peptidase_Metallo | MMP23B MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 1.58e-21 | 29 | 124 | 13 | IPR006026 |
| Domain | ZnMc | MMP23B MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 1.58e-21 | 29 | 124 | 13 | SM00235 |
| Domain | Hemopexin-like_dom | MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 5.40e-21 | 23 | 124 | 12 | IPR000585 |
| Domain | Hemopexin-like_repeat | MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 5.40e-21 | 23 | 124 | 12 | IPR018487 |
| Domain | HEMOPEXIN | MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 5.40e-21 | 23 | 124 | 12 | PS00024 |
| Domain | - | MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 5.40e-21 | 23 | 124 | 12 | 2.110.10.10 |
| Domain | HEMOPEXIN_2 | MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 5.40e-21 | 23 | 124 | 12 | PS51642 |
| Domain | HX | MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 5.40e-21 | 23 | 124 | 12 | SM00120 |
| Domain | Hemopexin | MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 5.40e-21 | 23 | 124 | 12 | PF00045 |
| Domain | Pept_M10A_stromelysin-type | MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP10 MMP13 MMP14 MMP15 MMP17 | 2.15e-20 | 18 | 124 | 11 | IPR016293 |
| Domain | Pept_M10A_Zn_BS | 9.03e-17 | 15 | 124 | 9 | IPR021158 | |
| Domain | Hemopexin_CS | 4.34e-16 | 17 | 124 | 9 | IPR018486 | |
| Domain | DISINTEGRIN_1 | 7.45e-09 | 40 | 124 | 7 | PS00427 | |
| Domain | Reprolysin | 7.45e-09 | 40 | 124 | 7 | PF01421 | |
| Domain | ADAM_MEPRO | 7.45e-09 | 40 | 124 | 7 | PS50215 | |
| Domain | DISINTEGRIN_2 | 7.45e-09 | 40 | 124 | 7 | PS50214 | |
| Domain | Peptidase_M12B | 7.45e-09 | 40 | 124 | 7 | IPR001590 | |
| Domain | Disintegrin_dom | 8.94e-09 | 41 | 124 | 7 | IPR001762 | |
| Domain | Pep_M12B_propep | 2.07e-07 | 39 | 124 | 6 | PF01562 | |
| Domain | Peptidase_M12B_N | 2.07e-07 | 39 | 124 | 6 | IPR002870 | |
| Domain | Lipase/vitellogenin | 3.77e-07 | 10 | 124 | 4 | IPR013818 | |
| Domain | TAG_lipase | 3.77e-07 | 10 | 124 | 4 | IPR000734 | |
| Domain | Lipase | 3.77e-07 | 10 | 124 | 4 | PF00151 | |
| Domain | Lipase_N | 3.77e-07 | 10 | 124 | 4 | IPR033906 | |
| Domain | Lipase_LIPH | 3.77e-07 | 10 | 124 | 4 | IPR016272 | |
| Domain | LIPASE_SER | 7.00e-07 | 26 | 124 | 5 | PS00120 | |
| Domain | Lipase_panc | 1.14e-06 | 4 | 124 | 3 | IPR002331 | |
| Domain | DUF3377 | 1.14e-06 | 4 | 124 | 3 | PF11857 | |
| Domain | Pept_M10A_metallopeptidase_C | 1.14e-06 | 4 | 124 | 3 | IPR021805 | |
| Domain | LH2 | 5.27e-06 | 18 | 124 | 4 | SM00308 | |
| Domain | - | 1.01e-05 | 21 | 124 | 4 | 2.60.60.20 | |
| Domain | PLAT | 1.01e-05 | 21 | 124 | 4 | PF01477 | |
| Domain | PLAT/LH2_dom | 1.01e-05 | 21 | 124 | 4 | IPR001024 | |
| Domain | PLAT | 1.01e-05 | 21 | 124 | 4 | PS50095 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.77e-05 | 24 | 124 | 4 | IPR013273 | |
| Domain | Rav1p_C | 4.37e-05 | 2 | 124 | 2 | IPR022033 | |
| Domain | Rav1p_C | 4.37e-05 | 2 | 124 | 2 | PF12234 | |
| Domain | - | 3.00e-04 | 20 | 124 | 3 | 4.10.70.10 | |
| Domain | Disintegrin | 3.48e-04 | 21 | 124 | 3 | PF00200 | |
| Domain | DISIN | 3.48e-04 | 21 | 124 | 3 | SM00050 | |
| Domain | WD40/YVTN_repeat-like_dom | 4.02e-04 | 335 | 124 | 9 | IPR015943 | |
| Domain | Quinoprotein_ADH-like_supfam | 4.21e-04 | 53 | 124 | 4 | IPR011047 | |
| Domain | WD40 | 4.25e-04 | 268 | 124 | 8 | SM00320 | |
| Domain | ADAM_spacer1 | 4.59e-04 | 23 | 124 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 4.59e-04 | 23 | 124 | 3 | PF05986 | |
| Domain | WD40_repeat | 4.69e-04 | 272 | 124 | 8 | IPR001680 | |
| Domain | ADAM_Cys-rich | 7.44e-04 | 27 | 124 | 3 | IPR006586 | |
| Domain | ACR | 7.44e-04 | 27 | 124 | 3 | SM00608 | |
| Domain | TSP_1 | 8.15e-04 | 63 | 124 | 4 | PF00090 | |
| Domain | WD40_repeat_dom | 8.33e-04 | 297 | 124 | 8 | IPR017986 | |
| Domain | TSP1 | 9.17e-04 | 65 | 124 | 4 | SM00209 | |
| Domain | TSP1_rpt | 9.17e-04 | 65 | 124 | 4 | IPR000884 | |
| Domain | TSP1 | 9.17e-04 | 65 | 124 | 4 | PS50092 | |
| Domain | - | 1.19e-03 | 119 | 124 | 5 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 1.19e-03 | 119 | 124 | 5 | IPR029058 | |
| Domain | - | 1.73e-03 | 333 | 124 | 8 | 2.130.10.10 | |
| Domain | WD40 | 1.73e-03 | 259 | 124 | 7 | PF00400 | |
| Domain | Cation_efflux | 1.90e-03 | 10 | 124 | 2 | IPR002524 | |
| Domain | Leu-rich_rpt_4 | 1.90e-03 | 10 | 124 | 2 | IPR025875 | |
| Domain | Cation_efflux | 1.90e-03 | 10 | 124 | 2 | PF01545 | |
| Domain | Phosphodiest/P_Trfase | 1.90e-03 | 10 | 124 | 2 | IPR002591 | |
| Domain | Phosphodiest | 1.90e-03 | 10 | 124 | 2 | PF01663 | |
| Domain | LRR_4 | 1.90e-03 | 10 | 124 | 2 | PF12799 | |
| Domain | Cation_efflux_TMD | 2.31e-03 | 11 | 124 | 2 | IPR027469 | |
| Domain | - | 2.31e-03 | 11 | 124 | 2 | 1.20.1510.10 | |
| Domain | WD_REPEATS_1 | 2.57e-03 | 278 | 124 | 7 | PS00678 | |
| Domain | WD_REPEATS_2 | 2.63e-03 | 279 | 124 | 7 | PS50082 | |
| Domain | WD_REPEATS_REGION | 2.63e-03 | 279 | 124 | 7 | PS50294 | |
| Domain | Rossmann-like_a/b/a_fold | 2.90e-03 | 43 | 124 | 3 | IPR014729 | |
| Domain | - | 2.90e-03 | 43 | 124 | 3 | 3.40.50.620 | |
| Pathway | WP_MATRIX_METALLOPROTEINASES | MMP23B MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 5.44e-21 | 29 | 104 | 13 | MM15981 |
| Pathway | WP_MATRIX_METALLOPROTEINASES | MMP23B MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 9.54e-21 | 30 | 104 | 13 | M39652 |
| Pathway | WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION | MMP23B MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 7.36e-18 | 46 | 104 | 13 | M46450 |
| Pathway | REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES | MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 3.46e-16 | 33 | 104 | 11 | M26976 |
| Pathway | REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES | MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 2.09e-15 | 38 | 104 | 11 | MM14611 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | ADAM15 ADAMTS5 MMP20 ADAM10 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 4.21e-15 | 114 | 104 | 15 | MM14571 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | ADAM15 ADAMTS5 MMP20 ADAM10 MMP25 MMP24 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 4.72e-15 | 140 | 104 | 16 | M587 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | MMP20 ADAM10 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 | 1.10e-12 | 64 | 104 | 11 | M26953 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.54e-10 | 53 | 104 | 9 | MM14566 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | ADAM15 ADAMTS5 MMP20 ADAM10 MMP25 MMP24 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 5.84e-10 | 300 | 104 | 16 | M610 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | ADAM15 ADAMTS5 MMP20 ADAM10 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 6.44e-10 | 258 | 104 | 15 | MM14572 |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_LIPID | 7.68e-06 | 6 | 104 | 3 | MM14738 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_LIPID | 1.34e-05 | 7 | 104 | 3 | M27069 | |
| Pathway | KEGG_GLYCEROLIPID_METABOLISM | 2.92e-05 | 49 | 104 | 5 | M15902 | |
| Pathway | WP_IL18_SIGNALING | 1.85e-04 | 273 | 104 | 9 | M39818 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.89e-04 | 39 | 104 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.89e-04 | 39 | 104 | 4 | MM15165 | |
| Pathway | REACTOME_DIGESTION | 4.71e-04 | 21 | 104 | 3 | MM15526 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 4.96e-04 | 50 | 104 | 4 | MM14796 | |
| Pathway | REACTOME_DIGESTION | 6.20e-04 | 23 | 104 | 3 | M27790 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 7.97e-04 | 25 | 104 | 3 | MM15557 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.06e-03 | 61 | 104 | 4 | M27103 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 1.11e-03 | 7 | 104 | 2 | M27199 | |
| Pathway | KEGG_MEDICUS_VARIANT_TMPRSS2_ERG_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION | 1.11e-03 | 7 | 104 | 2 | M47443 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 1.12e-03 | 28 | 104 | 3 | M27837 | |
| Pubmed | Functional interactions between matrix metalloproteinases and glycosaminoglycans. | MMP23B MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 4.74e-27 | 22 | 126 | 13 | 23421805 |
| Pubmed | MMP23B MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 4.74e-27 | 22 | 126 | 13 | 10419448 | |
| Pubmed | MMP23B MMP20 MMP24 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 3.88e-24 | 16 | 126 | 11 | 10949577 | |
| Pubmed | MMP23B MMP20 MMP24 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 2.16e-21 | 24 | 126 | 11 | 15734845 | |
| Pubmed | MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 5.02e-19 | 36 | 126 | 11 | 20587546 | |
| Pubmed | 2.97e-16 | 16 | 126 | 8 | 20484597 | ||
| Pubmed | 2.97e-16 | 16 | 126 | 8 | 37701782 | ||
| Pubmed | 2.26e-15 | 11 | 126 | 7 | 10949161 | ||
| Pubmed | 1.40e-14 | 7 | 126 | 6 | 11113146 | ||
| Pubmed | Expression analysis of the entire MMP and TIMP gene families during mouse tissue development. | 3.36e-13 | 19 | 126 | 7 | 15063736 | |
| Pubmed | DMXL2 ADAM15 USP24 HIPK2 MMP20 DMXL1 ADAMTS12 MMP25 MMP24 CLK1 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 CARS2 MMP14 MMP15 MMP17 | 2.26e-12 | 730 | 126 | 20 | 34857952 | |
| Pubmed | 5.88e-12 | 14 | 126 | 6 | 25636537 | ||
| Pubmed | Fine physical mapping of the human matrix metalloproteinase genes clustered on chromosome 11q22.3. | 1.20e-11 | 7 | 126 | 5 | 8921407 | |
| Pubmed | 1.20e-11 | 7 | 126 | 5 | 17307908 | ||
| Pubmed | Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP). | 1.20e-11 | 7 | 126 | 5 | 10922468 | |
| Pubmed | 1.20e-11 | 7 | 126 | 5 | 8216228 | ||
| Pubmed | Membrane-type matrix metalloproteinases: Their functions and regulations. | 1.20e-11 | 7 | 126 | 5 | 25794647 | |
| Pubmed | 1.20e-11 | 7 | 126 | 5 | 25770908 | ||
| Pubmed | Characterization of opticin digestion by proteases involved in osteoarthritis development. | 3.20e-11 | 8 | 126 | 5 | 23845380 | |
| Pubmed | Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites. | 7.18e-11 | 9 | 126 | 5 | 10986281 | |
| Pubmed | 1.64e-10 | 4 | 126 | 4 | 21925226 | ||
| Pubmed | [The system of matrix metalloproteinases and their role in patients with pulmonary tuberculosis]. | 1.64e-10 | 4 | 126 | 4 | 27797337 | |
| Pubmed | 4.47e-10 | 12 | 126 | 5 | 12149192 | ||
| Pubmed | 7.24e-10 | 13 | 126 | 5 | 12815621 | ||
| Pubmed | 7.24e-10 | 13 | 126 | 5 | 15944607 | ||
| Pubmed | 8.19e-10 | 5 | 126 | 4 | 20936527 | ||
| Pubmed | 8.19e-10 | 5 | 126 | 4 | 22464947 | ||
| Pubmed | 8.19e-10 | 5 | 126 | 4 | 25049354 | ||
| Pubmed | Membrane-type 1 MMP (MMP-14) cleaves at three sites in the aggrecan interglobular domain. | 8.19e-10 | 5 | 126 | 4 | 9688535 | |
| Pubmed | 8.19e-10 | 5 | 126 | 4 | 18035073 | ||
| Pubmed | 8.19e-10 | 5 | 126 | 4 | 12661033 | ||
| Pubmed | 1.12e-09 | 14 | 126 | 5 | 16236725 | ||
| Pubmed | 1.69e-09 | 186 | 126 | 10 | 20673868 | ||
| Pubmed | 1.69e-09 | 186 | 126 | 10 | 20452482 | ||
| Pubmed | Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. | 2.45e-09 | 6 | 126 | 4 | 10947989 | |
| Pubmed | 2.45e-09 | 6 | 126 | 4 | 18006768 | ||
| Pubmed | Matrix metalloproteinase polymorphisms and bladder cancer risk. | 2.45e-09 | 6 | 126 | 4 | 17178858 | |
| Pubmed | Proteolytic cleavage of extracellular secreted {alpha}-synuclein via matrix metalloproteinases. | 2.45e-09 | 6 | 126 | 4 | 15863497 | |
| Pubmed | 2.45e-09 | 6 | 126 | 4 | 12054629 | ||
| Pubmed | 2.45e-09 | 6 | 126 | 4 | 7998967 | ||
| Pubmed | Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness. | 2.45e-09 | 6 | 126 | 4 | 17473191 | |
| Pubmed | 5.70e-09 | 7 | 126 | 4 | 17033924 | ||
| Pubmed | Passenger Mutations Confound Interpretation of All Genetically Modified Congenic Mice. | 5.70e-09 | 7 | 126 | 4 | 26163370 | |
| Pubmed | 5.70e-09 | 7 | 126 | 4 | 19542530 | ||
| Pubmed | 5.70e-09 | 7 | 126 | 4 | 17607721 | ||
| Pubmed | Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors. | 5.70e-09 | 7 | 126 | 4 | 11169255 | |
| Pubmed | ATXN1 protein family and CIC regulate extracellular matrix remodeling and lung alveolarization. | 6.43e-09 | 19 | 126 | 5 | 22014525 | |
| Pubmed | KIR haplotype content at the allele level in 77 Northern Irish families. | 1.14e-08 | 8 | 126 | 4 | 17200871 | |
| Pubmed | 1.14e-08 | 8 | 126 | 4 | 16356191 | ||
| Pubmed | 1.14e-08 | 8 | 126 | 4 | 11865039 | ||
| Pubmed | 1.14e-08 | 8 | 126 | 4 | 18681957 | ||
| Pubmed | 2.04e-08 | 9 | 126 | 4 | 7749980 | ||
| Pubmed | Alternatively spliced forms of human killer inhibitory receptors. | 2.04e-08 | 9 | 126 | 4 | 8662091 | |
| Pubmed | 2.04e-08 | 9 | 126 | 4 | 16113801 | ||
| Pubmed | 2.04e-08 | 9 | 126 | 4 | 9108368 | ||
| Pubmed | 3.39e-08 | 10 | 126 | 4 | 11167130 | ||
| Pubmed | Matrix metalloproteinase localisation by in situ-RT-PCR in archival human breast biopsy material. | 4.64e-08 | 3 | 126 | 3 | 17669621 | |
| Pubmed | Pancreatic lipase and its related proteins: where are we now? | 4.64e-08 | 3 | 126 | 3 | 38081381 | |
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 17077200 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 18619594 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 23377317 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 21707906 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 37986083 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 21840960 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 30696053 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 18426080 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 20609440 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 1379598 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 17502998 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 24075964 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 28961241 | ||
| Pubmed | Missense polymorphisms in matrix metalloproteinase genes and skin cancer risk. | 4.64e-08 | 3 | 126 | 3 | 19064570 | |
| Pubmed | MMP-9 genetic polymorphism may confer susceptibility to COPD. | 4.64e-08 | 3 | 126 | 3 | 27173221 | |
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 22398316 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 19022250 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 21108787 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 22922035 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 27313452 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 2302735 | ||
| Pubmed | Collagenase expression and activity in the stromal cells from giant cell tumour of bone. | 4.64e-08 | 3 | 126 | 3 | 19442604 | |
| Pubmed | Associations of killer cell immunoglobulin- like receptor genes with rheumatoid arthritis. | 4.64e-08 | 3 | 126 | 3 | 22960345 | |
| Pubmed | MT1-MMP and ADAM10/17 exhibit a remarkable overlap of shedding properties. | 4.64e-08 | 3 | 126 | 3 | 35944080 | |
| Pubmed | Matrix metalloproteinase 1, 3, and 9 polymorphisms and esophageal squamous cell carcinoma risk. | 4.64e-08 | 3 | 126 | 3 | 25391977 | |
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 38527983 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 26031759 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 21872914 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 21232745 | ||
| Pubmed | Evaluation of the genetic diversity of KIR genes in patients with endometrial cancer. | 4.64e-08 | 3 | 126 | 3 | 38387251 | |
| Pubmed | Association of matrix metalloproteinase gene polymorphism with temporomandibular joint degeneration. | 4.64e-08 | 3 | 126 | 3 | 21244504 | |
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 22868188 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 35329213 | ||
| Pubmed | Matrix metalloproteinase gene polymorphisms in patients with rheumatoid arthritis. | 4.64e-08 | 3 | 126 | 3 | 19504098 | |
| Pubmed | Polymorphism +17 C/G in matrix metalloprotease MMP8 decreases lung cancer risk. | 4.64e-08 | 3 | 126 | 3 | 19094243 | |
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 32422377 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 25742789 | ||
| Pubmed | UVA-activated synthesis of metalloproteinases 1, 3 and 9 is prevented by a broad-spectrum sunscreen. | 4.64e-08 | 3 | 126 | 3 | 22092736 | |
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 18366705 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 29215835 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 35163727 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 18028894 | ||
| Interaction | MMP24 interactions | 5.59e-18 | 19 | 126 | 10 | int:MMP24 | |
| Interaction | MMP16 interactions | 7.74e-14 | 18 | 126 | 8 | int:MMP16 | |
| Interaction | MMP8 interactions | 1.84e-12 | 25 | 126 | 8 | int:MMP8 | |
| Interaction | MMP13 interactions | 1.30e-11 | 31 | 126 | 8 | int:MMP13 | |
| Interaction | MMP11 interactions | 4.75e-11 | 12 | 126 | 6 | int:MMP11 | |
| Interaction | BCAN interactions | 2.27e-09 | 36 | 126 | 7 | int:BCAN | |
| Interaction | ACAN interactions | 3.64e-09 | 22 | 126 | 6 | int:ACAN | |
| Interaction | MMP27 interactions | 3.95e-09 | 11 | 126 | 5 | int:MMP27 | |
| Interaction | MMP7 interactions | 1.38e-08 | 46 | 126 | 7 | int:MMP7 | |
| Interaction | MMP1 interactions | 1.05e-07 | 37 | 126 | 6 | int:MMP1 | |
| Interaction | MMP3 interactions | 1.46e-07 | 39 | 126 | 6 | int:MMP3 | |
| Interaction | MMP20 interactions | 2.97e-07 | 10 | 126 | 4 | int:MMP20 | |
| Interaction | MMP10 interactions | 1.11e-06 | 30 | 126 | 5 | int:MMP10 | |
| Interaction | MMP2 interactions | 1.22e-06 | 87 | 126 | 7 | int:MMP2 | |
| Interaction | TIMP1 interactions | 4.87e-06 | 40 | 126 | 5 | int:TIMP1 | |
| Interaction | CCL7 interactions | 9.77e-06 | 22 | 126 | 4 | int:CCL7 | |
| Interaction | TGFA interactions | 1.77e-05 | 87 | 126 | 6 | int:TGFA | |
| Interaction | TIMP3 interactions | 2.15e-05 | 90 | 126 | 6 | int:TIMP3 | |
| Interaction | MMP17 interactions | 2.77e-05 | 10 | 126 | 3 | int:MMP17 | |
| Interaction | MMP9 interactions | 6.25e-05 | 67 | 126 | 5 | int:MMP9 | |
| Interaction | HAPLN1 interactions | 8.26e-05 | 14 | 126 | 3 | int:HAPLN1 | |
| Interaction | EFHD2 interactions | 1.48e-04 | 127 | 126 | 6 | int:EFHD2 | |
| Interaction | KISS1 interactions | 1.52e-04 | 17 | 126 | 3 | int:KISS1 | |
| Interaction | GUCY1B1 interactions | 2.11e-04 | 47 | 126 | 4 | int:GUCY1B1 | |
| Interaction | RGMA interactions | 2.15e-04 | 19 | 126 | 3 | int:RGMA | |
| Cytoband | 11q22.3 | 3.49e-11 | 44 | 126 | 7 | 11q22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q22 | 2.06e-08 | 107 | 126 | 7 | chr11q22 | |
| Cytoband | 19q13.4 | 6.93e-05 | 79 | 126 | 4 | 19q13.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF233 ZNF784 ANKRD27 ZNF587B ZNF814 FUT1 KIR2DL3 ZNF468 KIR2DS4 ZNF418 KLC3 | 4.64e-04 | 1192 | 126 | 11 | chr19q13 |
| Cytoband | 16p13.3 | 5.89e-04 | 244 | 126 | 5 | 16p13.3 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | MMP23B MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 4.79e-24 | 24 | 100 | 13 | 891 |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 2.54e-06 | 18 | 100 | 4 | 620 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 3.20e-06 | 19 | 100 | 4 | 50 | |
| GeneFamily | Lipases|Arylacetamide deacetylase family | 5.97e-06 | 22 | 100 | 4 | 464 | |
| GeneFamily | CDC like kinases | 1.80e-04 | 4 | 100 | 2 | 480 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 4.36e-04 | 27 | 100 | 3 | 47 | |
| GeneFamily | WD repeat domain containing | 6.30e-04 | 262 | 100 | 7 | 362 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 1.61e-03 | 11 | 100 | 2 | 1168 | |
| GeneFamily | Ubiquitin specific peptidases | 3.68e-03 | 56 | 100 | 3 | 366 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class I | 4.87e-03 | 19 | 100 | 2 | 131 | |
| GeneFamily | Glycosyl transferases group 1 domain containing|Phosphatidylinositol glycan anchor biosynthesis | 5.94e-03 | 21 | 100 | 2 | 680 | |
| GeneFamily | NLR family | 8.36e-03 | 25 | 100 | 2 | 666 | |
| Coexpression | NABA_ECM_REGULATORS | ADAM15 MMP23B ADAMTS13 ADAMTS5 MMP20 ADAM10 ADAMTS12 MMP25 MMP24 SERPINA4 ADAMTS7 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 9.98e-21 | 238 | 126 | 21 | M3468 |
| Coexpression | NABA_ECM_REGULATORS | ADAM15 MMP23B ADAMTS13 ADAMTS5 MMP20 ADAM10 ADAMTS12 MMP25 MMP24 ADAMTS7 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 3.28e-19 | 242 | 126 | 20 | MM17062 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAM15 MMP23B ADAMTS13 ADAMTS5 MMP20 ADAM10 ADAMTS12 MMP25 MMP24 SERPINA4 ADAMTS7 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 7.69e-11 | 751 | 126 | 21 | M5885 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAM15 MMP23B ADAMTS13 ADAMTS5 MMP20 ADAM10 ADAMTS12 MMP25 MMP24 ADAMTS7 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 3.94e-10 | 738 | 126 | 20 | MM17058 |
| Coexpression | NABA_MATRISOME | LAMB4 ADAM15 MMP23B ADAMTS13 ADAMTS5 MMP20 ADAM10 ZP3 ADAMTS12 MMP25 MMP24 SERPINA4 ADAMTS7 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 6.68e-10 | 1026 | 126 | 23 | M5889 |
| Coexpression | NABA_MATRISOME | ADAM15 MMP23B ADAMTS13 ADAMTS5 MMP20 ADAM10 ZP3 ADAMTS12 MMP25 MMP24 ADAMTS7 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 1.46e-08 | 1008 | 126 | 21 | MM17056 |
| Coexpression | HALLMARK_COAGULATION | 3.59e-07 | 138 | 126 | 8 | M5946 | |
| Coexpression | WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP | 2.32e-06 | 20 | 126 | 4 | M1792 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DMXL2 MYCBP2 USP24 NBN MGLL ADAM10 ADCY9 GMPS TAOK3 PTPN13 ZNF451 ATAD2B ADAM17 ASCC3 PHIP | 1.61e-05 | 856 | 126 | 15 | M4500 |
| Coexpression | SAUL_SEN_MAYO | 3.08e-05 | 124 | 126 | 6 | M45803 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_MAC_UP | 4.84e-05 | 197 | 126 | 7 | M5401 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.61e-07 | 153 | 125 | 7 | 6a2a2379238133ce0ad714af130ffe02dd317247 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.61e-07 | 153 | 125 | 7 | faa442dd925b2b09919e93c492ccc3f19803ad24 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.74e-07 | 186 | 125 | 7 | 360c3e9e5c3a943e68e6939b4a47821bfc75b553 | |
| ToppCell | LPS-IL1RA-Myeloid-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-06 | 118 | 125 | 6 | 6053e19d040fb394f9c270361af07b0c5a4d47db | |
| ToppCell | LPS-IL1RA-Myeloid-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-06 | 118 | 125 | 6 | 811e8521129914eef46785a4227c1860e77d9096 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.53e-06 | 199 | 125 | 7 | 8c2ab13b5fffbab3da37041a7000d6537fc4db09 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.53e-06 | 199 | 125 | 7 | 76aab03a51681f0ce3369887cf71a884b0998ec5 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Granulocytic_cells|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.53e-06 | 199 | 125 | 7 | 7227e6be56e9f333ee143e1418d22de32a4ca66a | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Granulocytic_cells|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.58e-06 | 200 | 125 | 7 | 1592ca96c59eb053d0f0915afb337db9f3a40c91 | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-granulocyte-granulocyte_l8|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.46e-06 | 157 | 125 | 6 | 5098675f64342c41c5ca3551b24962d10c83e64d | |
| ToppCell | facs-Brain_Myeloid-Striatum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-06 | 157 | 125 | 6 | 9d4308312301cb922f156a7b6aededc9e1c62807 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.26e-06 | 165 | 125 | 6 | 436ce4bc75e1ba4351c439ccad19f84ad5bcb92f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.26e-06 | 165 | 125 | 6 | 242bdb7654f415391fb8e9bdc06412c7eee9c97e | |
| ToppCell | LPS_only-Myeloid-Neutrophils|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-05 | 179 | 125 | 6 | d0a03e498afcfeb657037889685ecd77bed07e6c | |
| ToppCell | LPS_only-Myeloid-Neutrophils-Neutrophils|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-05 | 179 | 125 | 6 | d034651a5a355a58f5e15db627869f4feebdfe35 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 181 | 125 | 6 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-05 | 182 | 125 | 6 | 243c783675df495ea4112dbf710712c44ea6b4f1 | |
| ToppCell | LPS_only-Myeloid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-05 | 182 | 125 | 6 | 666ac86ee5f6fa9241ae8d80340743707e54b278 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-05 | 182 | 125 | 6 | 18790a394dc32b3cef99cdbf826392c520e38b4a | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.39e-05 | 185 | 125 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.44e-05 | 186 | 125 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-05 | 188 | 125 | 6 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-05 | 188 | 125 | 6 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-05 | 188 | 125 | 6 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 189 | 125 | 6 | d52fc275976a625b014fa36f62ef07dddf1ffa43 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 189 | 125 | 6 | 199cec36fbbc1288771b9edf22143c34ab990af1 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 190 | 125 | 6 | 0a211e7dc515926b488f04c6248f6c7e61c2da87 | |
| ToppCell | ILEUM-non-inflamed-(8)_Activated_fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.62e-05 | 190 | 125 | 6 | 39fa110d19c97c7cac99f5fb91b26bc08e2f3b42 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 192 | 125 | 6 | 945153c41dde6e90d103206955e1707b54eb0665 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 192 | 125 | 6 | 6ab50579c63f31ca2cd41063a99b129f11c07510 | |
| ToppCell | Control-Myeloid-TRAM2|Myeloid / Condition, Lineage and Cell class | 1.72e-05 | 192 | 125 | 6 | 571fd71dad361a8b6c1bf9ad7184a89b3fbec667 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 1.77e-05 | 193 | 125 | 6 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.10e-05 | 199 | 125 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-KRT5-/KRT17+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.10e-05 | 199 | 125 | 6 | 3b1f56c8b40bb36922a31d2d440a8c468a8aa3f1 | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|LPS_only / Treatment groups by lineage, cell group, cell type | 2.16e-05 | 200 | 125 | 6 | 3504aeba7b30cac9c428ba3871c072e2202752b4 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.16e-05 | 200 | 125 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.16e-05 | 200 | 125 | 6 | fd1b6db3c62f5a205b769ba0e61433dae6285b67 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Granulocytic_cells|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.16e-05 | 200 | 125 | 6 | 0b7573ec4e9c67c7d11dd8f5011a70bade30e930 | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Granulocytic_cells|LPS_only / Treatment groups by lineage, cell group, cell type | 2.16e-05 | 200 | 125 | 6 | c5afebbc16024c60e84a67be81c78b0bfb73ec68 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Cdh13|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.11e-05 | 136 | 125 | 5 | 1f3000d5f105c87c80f8ae1dd2264bcd7f757a9c | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.52e-05 | 70 | 125 | 4 | 5720505ef03d65c73028616c808420e282823bde | |
| ToppCell | NS-critical-d_16-33-Myeloid-Monocyte-derived_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.19e-05 | 153 | 125 | 5 | 859de35b24c5d7d73be1c213b90b43362ee2e0eb | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-Trm_Th1/Th17|blood / Manually curated celltypes from each tissue | 8.13e-05 | 157 | 125 | 5 | c99cb26d831c25038f2aa1b1c0f7ba52facb2e7a | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_monocytic-non-classical_monocyte|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.37e-05 | 158 | 125 | 5 | be9d7410f152071e3af971bc09181818070228a0 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.63e-05 | 159 | 125 | 5 | 4b840da854390f8285c219314cff4434d7ffcacc | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Myeloid-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.63e-05 | 159 | 125 | 5 | a6093b230afdd4d91870d289c6ac91d1856666a3 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.63e-05 | 159 | 125 | 5 | d9e535cf9a0a2302268f2897b010dcecc6426e41 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.63e-05 | 159 | 125 | 5 | 29999c87f5823f734e5cbf8ea8b729ec017db9b3 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.88e-05 | 160 | 125 | 5 | bb1bb3673059768c0ea0160d29fff127f3a4ecb4 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.88e-05 | 160 | 125 | 5 | 76f49b8b4450fa8acd36326bfa36a5d1f4bd95fb | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.15e-05 | 161 | 125 | 5 | e227f7b711475624cf80e77f235b1783d88d57b4 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.15e-05 | 161 | 125 | 5 | 8280a029026c272cae9649b27575831b0dd4e242 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.70e-05 | 163 | 125 | 5 | 7a04192710f55acf5a4681d5f09942358fdb02ff | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.70e-05 | 163 | 125 | 5 | f21951e63188eb0c04675a8f81a0da495c26c007 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 165 | 125 | 5 | 622aca1d49bd8c917b131e4f4959d9dba411d22b | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 169 | 125 | 5 | a5964aef04093b460bbe29d5e2e7389f8fd2d46f | |
| ToppCell | facs-BAT-Fat-18m-Myeloid-granulocyte|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 169 | 125 | 5 | d3e6c75e5eda133fb6535cfe6c6a1026641f26ac | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 169 | 125 | 5 | 87116c33c5ca8cb1862e103e5607b1df4d264569 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 169 | 125 | 5 | e0076aa61b4ef3f836f5750005d0469d3982eb6d | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-04 | 169 | 125 | 5 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | facs-BAT-Fat-3m-Myeloid-granulocyte|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 170 | 125 | 5 | 8fd0a55266066a51266ab616c38c883e2680bcf4 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.18e-04 | 170 | 125 | 5 | 32917888c3f1d54302675c1d4de1fd3b7c79af5f | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 171 | 125 | 5 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 171 | 125 | 5 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-04 | 172 | 125 | 5 | a9e13aa36087170dadca421ba9de588e5a1cf715 | |
| ToppCell | ASK440-Epithelial-Transformed_epithelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.25e-04 | 172 | 125 | 5 | df3800bcd9777d02900eba0cfc26ab73de8a1d95 | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.35e-04 | 175 | 125 | 5 | 84d252f3e432231687613299bbea14978bb4b06b | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.35e-04 | 175 | 125 | 5 | a00c6fa9b33640710dd05a3799031147196f0986 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 176 | 125 | 5 | 086197acbfec4ac0c15b7e9721871aaa9e32e219 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 176 | 125 | 5 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-DC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-04 | 177 | 125 | 5 | 235254c08b44c20ee3cb62dd2ca0c7e46a2587e3 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 177 | 125 | 5 | 14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-DC-cDC2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-04 | 177 | 125 | 5 | b59d9fcf0a4964ef2d6274b6021a69cf7d335e0a | |
| ToppCell | E16.5-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-04 | 177 | 125 | 5 | f55332fe7fc32c23892ccf08b6b4d5b1ffcc0d3f | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-04 | 178 | 125 | 5 | da1695a936dbe3ca9ee3fb28ceb60511c47b35f8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-04 | 178 | 125 | 5 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-04 | 178 | 125 | 5 | 580fc1d45b82010c665a313b2e7a21e0116819ef | |
| ToppCell | facs-Pancreas-Exocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 179 | 125 | 5 | bbfbfb32773346080127055b5aafa36bbf7d0942 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 1.54e-04 | 180 | 125 | 5 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | LPS-IL1RA-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 180 | 125 | 5 | c0c07937839652e01df10cc1e70aa005800ea6f6 | |
| ToppCell | LPS-IL1RA-Myeloid-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 180 | 125 | 5 | 079c199425dd3c220f03c6dca1823946f07580a1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 181 | 125 | 5 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | Club-club-8|World / Class top | 1.62e-04 | 182 | 125 | 5 | 8111d917e588008d947021460ddf8f1e7ae1337a | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 182 | 125 | 5 | 506b63a233baf5e3baf924c13c88ab283b6e894f | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 183 | 125 | 5 | bc24145855bf4d027a8058bf92bc796c10f241bb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 183 | 125 | 5 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 183 | 125 | 5 | 4c325ee6da070513097a11445ec95b0415ffd8a2 | |
| ToppCell | facs-Thymus|facs / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 184 | 125 | 5 | 58beef66bbbde2479ec69dfef392d5941cedf230 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 184 | 125 | 5 | 1c857126c0ea0671f0d60b048efca288d348d653 | |
| ToppCell | facs-Heart-RV|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 185 | 125 | 5 | 7cf2b0db059605032bfae60cf1b93c4c62608f0c | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 189 | 125 | 5 | a3f6ebd1622d36d114e42f6e0618d7b2fe8b9a2f | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 189 | 125 | 5 | d86455cf20769d70d62e2c1dd92cbc93c67aada5 | |
| ToppCell | facs-Heart-LV-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 189 | 125 | 5 | d424d2554595b2304219f7324406b401711af7c2 | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.94e-04 | 189 | 125 | 5 | 46c5b975fb9d33017f2d9b7770d45a8bdf95baa2 | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 189 | 125 | 5 | 393ec5954a12d6cf67bb435dcc34ff0b14c81e9f | |
| ToppCell | facs-Heart-LV-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 189 | 125 | 5 | bec57459ad4bab15b2532b57722549fec2e771fb | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 189 | 125 | 5 | 84036d1257f6b18f47cfc7ac5e6ed6ea3553c235 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Erythrophagocytic_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 1.98e-04 | 190 | 125 | 5 | 96c6078619e85f630c9754aca5d6066433e22836 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 190 | 125 | 5 | 1ff2295c9fc94ea21fff286706b739d0deb032d0 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 190 | 125 | 5 | 89d1d686cc683206534e2157554d7d0df5d53497 | |
| Computational | MMPs. | 9.02e-13 | 21 | 77 | 8 | MODULE_562 | |
| Computational | Genes in the cancer module 210. | 1.32e-11 | 28 | 77 | 8 | MODULE_210 | |
| Computational | Genes in the cancer module 211. | 7.39e-09 | 11 | 77 | 5 | MODULE_211 | |
| Computational | Metal ion (zinc) binding. | 7.23e-07 | 45 | 77 | 6 | MODULE_280 | |
| Computational | Genes in the cancer module 371. | 9.67e-07 | 26 | 77 | 5 | MODULE_371 | |
| Computational | Genes in the cancer module 107. | 1.41e-06 | 79 | 77 | 7 | MODULE_107 | |
| Computational | Genes in the cancer module 172. | 5.25e-06 | 96 | 77 | 7 | MODULE_172 | |
| Computational | Catabolic peptidases. | 4.02e-05 | 89 | 77 | 6 | MODULE_209 | |
| Computational | Metal / Ca ion binding. | 3.70e-04 | 133 | 77 | 6 | MODULE_324 | |
| Computational | Genes in the cancer module 417. | 4.93e-04 | 22 | 77 | 3 | MODULE_417 | |
| Computational | Neighborhood of SERPINI2 | 7.26e-04 | 25 | 77 | 3 | GNF2_SERPINI2 | |
| Computational | Neighborhood of SPINK1 | 9.13e-04 | 27 | 77 | 3 | GNF2_SPINK1 | |
| Computational | Neighborhood of PTPN9 | 9.32e-04 | 61 | 77 | 4 | MORF_PTPN9 | |
| Computational | Neighborhood of CNTN1 | 1.04e-03 | 108 | 77 | 5 | MORF_CNTN1 | |
| Drug | malolactomycin D | MMP23B MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 6.90e-22 | 32 | 125 | 13 | CID006449115 |
| Drug | diacerein | MMP23B ADAMTS5 MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 3.19e-19 | 63 | 125 | 14 | CID000026248 |
| Drug | DA-125 | MMP23B MMP20 MMP24 MMP1 MMP3 MMP8 MMP10 MMP13 MMP15 MMP17 TOP2B | 6.28e-19 | 26 | 125 | 11 | CID000114758 |
| Drug | AC1L1GXT | MMP23B MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 1.71e-16 | 74 | 125 | 13 | CID000003890 |
| Drug | AC1NSU5S | NOX5 MMP23B TNFAIP8L1 MMP20 MMP24 SERPINA4 MMP1 MMP3 MMP8 MMP10 MMP13 MMP15 MMP17 | 2.06e-16 | 75 | 125 | 13 | CID005316299 |
| Drug | isoflavone | MMP23B TNFAIP8L1 MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 PHIP TOP2B | 3.19e-16 | 155 | 125 | 16 | CID000072304 |
| Drug | mercuric acetate | 4.72e-16 | 30 | 125 | 10 | CID000015337 | |
| Drug | 4-aminophenyl | MMP23B MMP20 ZP3 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP15 MMP17 | 7.49e-16 | 62 | 125 | 12 | CID000181201 |
| Drug | AC1L1DD6 | MMP23B ADAMTS5 MMP20 ADAM10 MMP25 MMP24 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 3.20e-15 | 179 | 125 | 16 | CID000002299 |
| Drug | A0395 | MMP23B MMP20 ADAM10 MMP24 ADAM17 MMP1 MMP3 MMP8 MMP10 MMP13 MMP15 MMP17 | 8.53e-15 | 75 | 125 | 12 | CID009906466 |
| Drug | carvedilol | MMP23B TNFAIP8L1 MMP20 ADCY9 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 1.32e-14 | 161 | 125 | 15 | CID000002585 |
| Drug | quercetin | LAMB4 NOX5 MMP23B TNFAIP8L1 MMP20 AKR7A2 MMP25 MMP24 FARSA SERPINA4 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 PHIP TOP2B SOD1 | 2.06e-14 | 482 | 125 | 22 | CID005280343 |
| Drug | quinacrine | NOX5 MMP23B TNFAIP8L1 MMP20 ADCY9 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 TOP2B | 2.48e-14 | 243 | 125 | 17 | CID000000237 |
| Drug | MMI270 | 2.75e-14 | 18 | 125 | 8 | CID000446504 | |
| Drug | pirfenidone | MMP23B TNFAIP8L1 MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 3.19e-14 | 138 | 125 | 14 | CID000040632 |
| Drug | marimastat | TNFAIP8L1 MMP20 ADAM10 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 | 1.03e-13 | 68 | 125 | 11 | CID000119031 |
| Drug | 1,10-phenanthroline | MMP23B MMP20 ADAM10 MMP25 MMP24 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 ENDOV SOD1 | 1.16e-13 | 267 | 125 | 17 | CID000001318 |
| Drug | oxidized glutathione | NOX5 MMP23B MMP20 AKR7A2 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 SOD1 | 1.34e-13 | 227 | 125 | 16 | CID000000975 |
| Drug | titanium | MMP23B TNFAIP8L1 MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 5.82e-13 | 170 | 125 | 14 | CID000023963 |
| Drug | AC1L9M3B | 1.23e-12 | 61 | 125 | 10 | CID000448562 | |
| Drug | CGS 27023A | 2.01e-12 | 9 | 125 | 6 | ctd:C097658 | |
| Drug | dioxane | MMP23B MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 TOP2B SOD1 | 3.74e-11 | 278 | 125 | 15 | CID000031275 |
| Drug | gluconate | MMP23B MMP20 ADCY9 AKR7A2 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 5.86e-11 | 287 | 125 | 15 | CID000000604 |
| Drug | AC1L1HMM | NOX5 MMP23B TNFAIP8L1 NBN MMP20 ADCY9 MMP25 MMP24 OSBPL2 CYP7B1 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 5.95e-11 | 516 | 125 | 19 | CID000004196 |
| Drug | AC1L1B55 | NOX5 MMP23B TNFAIP8L1 MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 PHIP TOP2B SOD1 | 6.01e-11 | 454 | 125 | 18 | CID000001287 |
| Drug | Pro-leu-gly | 7.65e-11 | 26 | 125 | 7 | CID000169533 | |
| Drug | enantio-PAF-C16 | NOX5 MMP23B MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 7.74e-11 | 244 | 125 | 14 | CID000002499 |
| Drug | raloxifene | MMP23B PPP1R13B TNFAIP8L1 MMP20 MMP24 PTPN13 OSBPL2 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP15 MMP17 TOP2B | 9.86e-11 | 351 | 125 | 16 | CID000005035 |
| Drug | glutathione reduced | NOX5 MMP23B MMP20 AKR7A2 MMP25 MMP24 CYP7B1 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 PHIP TOP2B SOD1 | 1.06e-10 | 534 | 125 | 19 | CID000000745 |
| Drug | dibutyryl cyclic 3',5'-AMP | LAMB4 NOX5 MMP23B TNFAIP8L1 MMP20 ADCY9 MMP25 MMP24 RAPGEF3 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 TOP2B | 2.44e-10 | 561 | 125 | 19 | CID000002460 |
| Drug | Marimastat | 2.54e-10 | 8 | 125 | 5 | DB00786 | |
| Drug | Ro 32-3555 | 2.54e-10 | 8 | 125 | 5 | CID000193987 | |
| Drug | peroxynitrite | NOX5 MMP23B MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 SOD1 | 2.20e-09 | 373 | 125 | 15 | CID000104806 |
| Drug | 17-isoprogesterone | MMP23B PAQR8 HIPK2 TNFAIP8L1 NBN FBXO11 MMP20 ZP3 ADCY9 MMP25 MMP24 LIPC PTPN13 OSBPL2 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 MVK SOD1 | 4.26e-09 | 1170 | 125 | 25 | CID000004920 |
| Drug | beta-sulfone 7f | 4.31e-09 | 5 | 125 | 4 | CID011526076 | |
| Drug | alpha-sulfone 27e | 4.31e-09 | 5 | 125 | 4 | CID011719408 | |
| Drug | CTS-1027 | 4.31e-09 | 5 | 125 | 4 | CID003342298 | |
| Drug | SC-276 | 4.31e-09 | 5 | 125 | 4 | CID009802768 | |
| Drug | alpha-sulfone 35g | 4.31e-09 | 5 | 125 | 4 | CID011705502 | |
| Drug | beta-sulfone 7d | 4.31e-09 | 5 | 125 | 4 | CID011548264 | |
| Drug | alpha-sulfone 27g | 4.31e-09 | 5 | 125 | 4 | CID011561491 | |
| Drug | beta-sulfone 7e | 4.31e-09 | 5 | 125 | 4 | CID011641261 | |
| Drug | beta-sulfone 7b | 4.31e-09 | 5 | 125 | 4 | CID009867183 | |
| Drug | alpha-sulfone 27d | 4.31e-09 | 5 | 125 | 4 | CID011532911 | |
| Drug | alpha-sulfone 27b | 4.31e-09 | 5 | 125 | 4 | CID011697282 | |
| Drug | beta-sulfone 7c | 4.31e-09 | 5 | 125 | 4 | CID011613649 | |
| Drug | aldosterone | NOX5 MMP23B MMP20 MMP25 MMP24 UTP4 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 5.11e-09 | 397 | 125 | 15 | CID000005839 |
| Drug | FN-439 | 5.72e-09 | 13 | 125 | 5 | CID000004648 | |
| Drug | genistein | LAMB4 NOX5 ADAM15 MMP23B TNFAIP8L1 MMP20 MMP25 MMP24 SERPINA4 ADAMTS7 PWP2 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 PHIP TOP2B SOD1 | 8.23e-09 | 1117 | 125 | 24 | CID005280961 |
| Drug | Ageladine A | 8.86e-09 | 14 | 125 | 5 | ctd:C482289 | |
| Drug | AC1L1G2K | 2.02e-08 | 84 | 125 | 8 | CID000003498 | |
| Drug | losartan | NOX5 MMP23B MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 2.20e-08 | 378 | 125 | 14 | CID000003961 |
| Drug | prinomastat | 2.38e-08 | 33 | 125 | 6 | CID000466151 | |
| Drug | polyethylenimine | 3.73e-08 | 128 | 125 | 9 | CID000009033 | |
| Drug | NSC236997 | NOX5 MMP23B MMP20 ADCY9 AKR7A2 MMP24 LIPC MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP15 MMP17 SOD1 | 4.51e-08 | 539 | 125 | 16 | CID000005300 |
| Drug | latanoprost acid | 7.99e-08 | 40 | 125 | 6 | CID006441636 | |
| Drug | pseudococaine | MMP23B TNFAIP8L1 MMP20 ADCY9 MMP25 MMP24 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 9.70e-08 | 570 | 125 | 16 | CID000002826 |
| Drug | N-methylmesoporphyrin | 1.08e-07 | 42 | 125 | 6 | CID000444708 | |
| Drug | noradrealine | NOX5 MMP23B TNFAIP8L1 MMP20 ADCY9 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 | 1.09e-07 | 575 | 125 | 16 | CID000000951 |
| Drug | 17alpha-estradiol | NOX5 ADAM15 MMP23B TNFAIP8L1 MMP20 ADCY9 MMP25 MMP24 LIPC PTPN13 OSBPL2 PWP2 CYP7B1 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 TOP2B SOD1 | 1.50e-07 | 1303 | 125 | 24 | CID000000450 |
| Drug | alpha-sulfone 21 | 1.62e-07 | 3 | 125 | 3 | CID009822926 | |
| Drug | dithizone | 1.80e-07 | 24 | 125 | 5 | CID000657262 | |
| Drug | magnesium | LAMB4 MMP23B MGLL MMP20 ADCY9 YARS2 GMPS MMP25 MMP24 FARSA ADAM17 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 ENDOV TOP2B MVK SOD1 | 2.04e-07 | 1325 | 125 | 24 | CID000000888 |
| Drug | Matrix Metalloproteinase Inhibitors | 2.77e-07 | 11 | 125 | 4 | ctd:D061965 | |
| Drug | benzoyl isothiocyanate | 2.77e-07 | 11 | 125 | 4 | CID000068284 | |
| Drug | formosanin C | 5.96e-07 | 13 | 125 | 4 | ctd:C067584 | |
| Drug | esculetin | 6.29e-07 | 56 | 125 | 6 | CID005281416 | |
| Drug | carbamoylphosphonic acid | 6.44e-07 | 4 | 125 | 3 | CID013879809 | |
| Drug | 3-hydroxypicolinic acid | 6.44e-07 | 4 | 125 | 3 | ctd:C049246 | |
| Drug | alpha-sulfone 35h | 6.44e-07 | 4 | 125 | 3 | CID011684849 | |
| Drug | alpha-sulfone 35a | 6.44e-07 | 4 | 125 | 3 | CID011633617 | |
| Drug | alpha-sulfone 35c | 6.44e-07 | 4 | 125 | 3 | CID011533203 | |
| Drug | alpha-sulfone 35d | 6.44e-07 | 4 | 125 | 3 | CID009954521 | |
| Drug | acetate | NOX5 MMP23B MMP20 MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 SOD1 | 1.06e-06 | 599 | 125 | 15 | CID000000175 |
| Drug | ethylnylestradiol | MMP23B TNFAIP8L1 NBN POU3F1 MMP20 RXRB ADCY9 MMP25 MMP24 LIPC OSBPL2 CYP7B1 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 SOD1 | 1.17e-06 | 1251 | 125 | 22 | CID000003285 |
| Drug | MMP-3 inhibitor | 1.60e-06 | 5 | 125 | 3 | CID010549329 | |
| Drug | PD-0200347 | 1.60e-06 | 5 | 125 | 3 | ctd:C497431 | |
| Drug | prinomastat | 1.60e-06 | 5 | 125 | 3 | ctd:C113282 | |
| Drug | 1-(3',5'-dihydroxyphenoxy)-7-(2'',4'',6''-trihydroxyphenoxy)-2,4,9-trihydroxydibenzo-1,4,-dioxin | 1.60e-06 | 5 | 125 | 3 | ctd:C540360 | |
| Drug | CGS 25966 | 1.60e-06 | 5 | 125 | 3 | CID009821883 | |
| Drug | AC1NRBJE | 1.99e-06 | 152 | 125 | 8 | CID005288446 | |
| Drug | hydroxyl radical | 2.11e-06 | 206 | 125 | 9 | CID000157350 | |
| Drug | tricaprylin | 2.94e-06 | 41 | 125 | 5 | CID000010850 | |
| Drug | Pz-plgpa | 3.15e-06 | 19 | 125 | 4 | CID000152296 | |
| Drug | 4-aminoproline | 3.19e-06 | 6 | 125 | 3 | CID000124558 | |
| Drug | varespladib methyl | 3.19e-06 | 6 | 125 | 3 | ctd:C545088 | |
| Drug | 2-Amino-5-mercapto-1,3,4-thiadiazole | 3.19e-06 | 6 | 125 | 3 | CID002723847 | |
| Drug | Hydroxamate 12 | 3.19e-06 | 6 | 125 | 3 | CID010594000 | |
| Drug | dieckol | 3.19e-06 | 6 | 125 | 3 | ctd:C503840 | |
| Drug | phosphocitrate | 3.92e-06 | 20 | 125 | 4 | CID000123745 | |
| Drug | Pz-peptide | 3.92e-06 | 20 | 125 | 4 | CID000161208 | |
| Drug | metrizamide | 3.92e-06 | 20 | 125 | 4 | CID000035734 | |
| Drug | Agronal | 4.86e-06 | 79 | 125 | 6 | CID000007511 | |
| Drug | glycylvaline | 5.27e-06 | 46 | 125 | 5 | CID000097417 | |
| Drug | tetracycline CMT-8 | 5.56e-06 | 7 | 125 | 3 | ctd:C117153 | |
| Drug | CGS 27023A Analog 51 | 5.56e-06 | 7 | 125 | 3 | CID010594938 | |
| Drug | AC1ND30P | 5.87e-06 | 22 | 125 | 4 | CID004568793 | |
| Drug | Cbz-gplgp | 5.87e-06 | 22 | 125 | 4 | CID000193354 | |
| Drug | nitric oxide | NOX5 MMP23B TNFAIP8L1 MMP20 ADCY9 AKR7A2 GMPS MMP25 MMP24 MMP1 MMP3 MMP8 MMP9 MMP10 MMP13 MMP14 MMP15 MMP17 SOD1 | 6.40e-06 | 1075 | 125 | 19 | CID000145068 |
| Drug | AC1L4OCG | 8.83e-06 | 51 | 125 | 5 | CID000102535 | |
| Disease | interstitial collagenase measurement | 5.25e-10 | 11 | 123 | 5 | EFO_0008193 | |
| Disease | thoracic aortic aneurysm (is_marker_for) | 2.79e-07 | 14 | 123 | 4 | DOID:14004 (is_marker_for) | |
| Disease | thoracic aortic aneurysm (biomarker_via_orthology) | 2.82e-07 | 4 | 123 | 3 | DOID:14004 (biomarker_via_orthology) | |
| Disease | osteoarthritis (is_marker_for) | 3.41e-07 | 35 | 123 | 5 | DOID:8398 (is_marker_for) | |
| Disease | matrix metalloproteinase 1 measurement | 3.79e-07 | 15 | 123 | 4 | EFO_0010588 | |
| Disease | rheumatoid arthritis (is_marker_for) | 4.49e-07 | 69 | 123 | 6 | DOID:7148 (is_marker_for) | |
| Disease | matrix metalloproteinase 7 measurement | 3.90e-06 | 8 | 123 | 3 | EFO_0010591 | |
| Disease | amyotrophic lateral sclerosis (is_marker_for) | 6.30e-06 | 29 | 123 | 4 | DOID:332 (is_marker_for) | |
| Disease | arteriosclerosis (is_implicated_in) | 8.29e-06 | 31 | 123 | 4 | DOID:2349 (is_implicated_in) | |
| Disease | abdominal aortic aneurysm (is_marker_for) | 8.30e-06 | 10 | 123 | 3 | DOID:7693 (is_marker_for) | |
| Disease | Chronic Obstructive Airway Disease | 1.07e-05 | 33 | 123 | 4 | C0024117 | |
| Disease | Chronic Airflow Obstruction | 1.07e-05 | 33 | 123 | 4 | C1527303 | |
| Disease | degenerative disc disease (biomarker_via_orthology) | 1.14e-05 | 11 | 123 | 3 | DOID:90 (biomarker_via_orthology) | |
| Disease | Autoinflammatory disorder | 1.36e-05 | 35 | 123 | 4 | C3860213 | |
| Disease | Metaphyseal anadysplasia | 1.72e-05 | 2 | 123 | 2 | C0432226 | |
| Disease | varicose veins (is_implicated_in) | 1.72e-05 | 2 | 123 | 2 | DOID:799 (is_implicated_in) | |
| Disease | thrombosis (is_implicated_in) | 3.10e-05 | 15 | 123 | 3 | DOID:0060903 (is_implicated_in) | |
| Disease | immunoglobulin light chain amyloidosis (is_marker_for) | 5.16e-05 | 3 | 123 | 2 | DOID:0080933 (is_marker_for) | |
| Disease | meningococcal meningitis (biomarker_via_orthology) | 5.16e-05 | 3 | 123 | 2 | DOID:0080176 (biomarker_via_orthology) | |
| Disease | Takayasu's arteritis (is_marker_for) | 5.16e-05 | 3 | 123 | 2 | DOID:2508 (is_marker_for) | |
| Disease | conjunctivochalasis (is_marker_for) | 5.16e-05 | 3 | 123 | 2 | DOID:4250 (is_marker_for) | |
| Disease | myocardial infarction (is_implicated_in) | 6.07e-05 | 99 | 123 | 5 | DOID:5844 (is_implicated_in) | |
| Disease | congestive heart failure (biomarker_via_orthology) | 8.78e-05 | 107 | 123 | 5 | DOID:6000 (biomarker_via_orthology) | |
| Disease | esophagus adenocarcinoma (is_implicated_in) | 8.90e-05 | 21 | 123 | 3 | DOID:4914 (is_implicated_in) | |
| Disease | gastric ulcer (biomarker_via_orthology) | 8.90e-05 | 21 | 123 | 3 | DOID:10808 (biomarker_via_orthology) | |
| Disease | carotid artery disease (is_implicated_in) | 1.03e-04 | 22 | 123 | 3 | DOID:3407 (is_implicated_in) | |
| Disease | response to anti-thyroid drug | 1.03e-04 | 4 | 123 | 2 | EFO_0007838 | |
| Disease | psoriatic arthritis (is_marker_for) | 1.03e-04 | 4 | 123 | 2 | DOID:9008 (is_marker_for) | |
| Disease | blood tin measurement | 1.52e-04 | 25 | 123 | 3 | EFO_0021530 | |
| Disease | matrilysin measurement | 1.71e-04 | 5 | 123 | 2 | EFO_0008227 | |
| Disease | anodontia (is_implicated_in) | 1.71e-04 | 5 | 123 | 2 | DOID:13714 (is_implicated_in) | |
| Disease | adrenoleukodystrophy (is_marker_for) | 1.71e-04 | 5 | 123 | 2 | DOID:10588 (is_marker_for) | |
| Disease | lysophosphatidylethanolamine 16:0 measurement | 1.71e-04 | 26 | 123 | 3 | EFO_0010366 | |
| Disease | osteoarthritis (is_implicated_in) | 2.15e-04 | 28 | 123 | 3 | DOID:8398 (is_implicated_in) | |
| Disease | primary biliary cholangitis (biomarker_via_orthology) | 2.15e-04 | 28 | 123 | 3 | DOID:12236 (biomarker_via_orthology) | |
| Disease | allergic contact dermatitis (biomarker_via_orthology) | 2.56e-04 | 6 | 123 | 2 | DOID:3042 (biomarker_via_orthology) | |
| Disease | Lipid Metabolism, Inborn Errors | 2.56e-04 | 6 | 123 | 2 | C0023772 | |
| Disease | stromelysin-2 measurement | 2.56e-04 | 6 | 123 | 2 | EFO_0802095 | |
| Disease | carotid stenosis (is_implicated_in) | 2.56e-04 | 6 | 123 | 2 | DOID:13001 (is_implicated_in) | |
| Disease | Aortic Diseases | 2.56e-04 | 6 | 123 | 2 | C0003493 | |
| Disease | Down syndrome (is_implicated_in) | 2.56e-04 | 6 | 123 | 2 | DOID:14250 (is_implicated_in) | |
| Disease | atrial fibrillation (is_marker_for) | 3.21e-04 | 32 | 123 | 3 | DOID:0060224 (is_marker_for) | |
| Disease | Asthma | 3.56e-04 | 80 | 123 | 4 | C0004096 | |
| Disease | matrix metalloproteinase 10 measurement | 3.57e-04 | 7 | 123 | 2 | EFO_0010589 | |
| Disease | degenerative disc disease (implicated_via_orthology) | 3.57e-04 | 7 | 123 | 2 | DOID:90 (implicated_via_orthology) | |
| Disease | breast cancer (is_implicated_in) | 4.24e-04 | 150 | 123 | 5 | DOID:1612 (is_implicated_in) | |
| Disease | crescentic glomerulonephritis (biomarker_via_orthology) | 4.75e-04 | 8 | 123 | 2 | DOID:13139 (biomarker_via_orthology) | |
| Disease | cognitive disorder (biomarker_via_orthology) | 4.75e-04 | 8 | 123 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | cataract (is_marker_for) | 6.09e-04 | 9 | 123 | 2 | DOID:83 (is_marker_for) | |
| Disease | Marfan Syndrome, Type I | 6.09e-04 | 9 | 123 | 2 | C4721845 | |
| Disease | Aortic Aneurysm, Abdominal | 7.59e-04 | 10 | 123 | 2 | C0162871 | |
| Disease | pleural tuberculosis (is_marker_for) | 7.59e-04 | 10 | 123 | 2 | DOID:106 (is_marker_for) | |
| Disease | glomerulosclerosis (biomarker_via_orthology) | 7.59e-04 | 10 | 123 | 2 | DOID:0050851 (biomarker_via_orthology) | |
| Disease | phosphatidylethanolamine measurement | 8.09e-04 | 173 | 123 | 5 | EFO_0010228 | |
| Disease | coronary artery disease (is_implicated_in) | 8.28e-04 | 100 | 123 | 4 | DOID:3393 (is_implicated_in) | |
| Disease | glomerulosclerosis (implicated_via_orthology) | 9.25e-04 | 11 | 123 | 2 | DOID:0050851 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (is_implicated_in) | 9.25e-04 | 11 | 123 | 2 | DOID:14004 (is_implicated_in) | |
| Disease | Marfan Syndrome | 9.25e-04 | 11 | 123 | 2 | C0024796 | |
| Disease | pulmonary emphysema (is_implicated_in) | 9.25e-04 | 11 | 123 | 2 | DOID:9675 (is_implicated_in) | |
| Disease | diabetic angiopathy (is_marker_for) | 1.11e-03 | 12 | 123 | 2 | DOID:11713 (is_marker_for) | |
| Disease | abdominal aortic aneurysm (is_implicated_in) | 1.11e-03 | 12 | 123 | 2 | DOID:7693 (is_implicated_in) | |
| Disease | prostate specific antigen measurement | 1.17e-03 | 188 | 123 | 5 | EFO_0004624 | |
| Disease | liver cirrhosis (implicated_via_orthology) | 1.30e-03 | 13 | 123 | 2 | DOID:5082 (implicated_via_orthology) | |
| Disease | hypothyroidism (implicated_via_orthology) | 1.30e-03 | 13 | 123 | 2 | DOID:1459 (implicated_via_orthology) | |
| Disease | hypertension (is_marker_for) | 1.42e-03 | 53 | 123 | 3 | DOID:10763 (is_marker_for) | |
| Disease | systemic scleroderma (is_marker_for) | 1.42e-03 | 53 | 123 | 3 | DOID:418 (is_marker_for) | |
| Disease | skin melanoma (is_implicated_in) | 1.52e-03 | 14 | 123 | 2 | DOID:8923 (is_implicated_in) | |
| Disease | abdominal aortic aneurysm (biomarker_via_orthology) | 1.52e-03 | 14 | 123 | 2 | DOID:7693 (biomarker_via_orthology) | |
| Disease | atrial fibrillation (is_implicated_in) | 1.52e-03 | 14 | 123 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | autosomal dominant polycystic kidney disease (is_marker_for) | 1.52e-03 | 14 | 123 | 2 | DOID:898 (is_marker_for) | |
| Disease | intracranial aneurysm (is_marker_for) | 1.52e-03 | 14 | 123 | 2 | DOID:10941 (is_marker_for) | |
| Disease | level of Phosphatidylethanolamine (18:1_18:1) in blood serum | 1.52e-03 | 14 | 123 | 2 | OBA_2045142 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.74e-03 | 303 | 123 | 6 | EFO_0004612, EFO_0020945 | |
| Disease | quinate measurement | 1.75e-03 | 15 | 123 | 2 | EFO_0021167 | |
| Disease | response to platinum based chemotherapy, magnesium measurement | 1.75e-03 | 15 | 123 | 2 | EFO_0004647, EFO_0004845 | |
| Disease | Alzheimer's disease (biomarker_via_orthology) | 1.85e-03 | 58 | 123 | 3 | DOID:10652 (biomarker_via_orthology) | |
| Disease | cholesteatoma of middle ear (is_marker_for) | 1.99e-03 | 16 | 123 | 2 | DOID:10964 (is_marker_for) | |
| Disease | level of Phosphatidylethanolamine (16:0_20:4) in blood serum | 1.99e-03 | 16 | 123 | 2 | OBA_2045137 | |
| Disease | retinopathy | 2.25e-03 | 17 | 123 | 2 | EFO_0003839 | |
| Disease | ocular hypertension (biomarker_via_orthology) | 2.25e-03 | 17 | 123 | 2 | DOID:9282 (biomarker_via_orthology) | |
| Disease | matrix metalloproteinase 12 measurement | 2.52e-03 | 18 | 123 | 2 | EFO_0010590 | |
| Disease | Oral Submucous Fibrosis | 2.52e-03 | 18 | 123 | 2 | C0029172 | |
| Disease | level of Sphingomyelin (d34:1) in blood serum | 2.52e-03 | 18 | 123 | 2 | OBA_2045175 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 2.66e-03 | 330 | 123 | 6 | EFO_0004529, EFO_0004612 | |
| Disease | myocardial infarction (implicated_via_orthology) | 2.67e-03 | 66 | 123 | 3 | DOID:5844 (implicated_via_orthology) | |
| Disease | blood metabolite measurement | 2.81e-03 | 19 | 123 | 2 | EFO_0005664 | |
| Disease | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | 2.81e-03 | 19 | 123 | 2 | EFO_0004612, EFO_0008589 | |
| Disease | level of Phosphatidylethanolamine (18:0_20:4) in blood serum | 2.81e-03 | 19 | 123 | 2 | OBA_2045140 | |
| Disease | Prostate cancer, familial | 3.03e-03 | 69 | 123 | 3 | C2931456 | |
| Disease | white matter lesion progression measurement | 3.29e-03 | 71 | 123 | 3 | EFO_0007746 | |
| Disease | Contact Dermatitis | 3.29e-03 | 71 | 123 | 3 | C0011616 | |
| Disease | Contact hypersensitivity | 3.29e-03 | 71 | 123 | 3 | C0162351 | |
| Disease | Liver diseases | 3.42e-03 | 72 | 123 | 3 | C0023895 | |
| Disease | Liver Dysfunction | 3.42e-03 | 72 | 123 | 3 | C0086565 | |
| Disease | Retinal Degeneration | 3.44e-03 | 21 | 123 | 2 | C0035304 | |
| Disease | osteoarthritis (biomarker_via_orthology) | 3.44e-03 | 21 | 123 | 2 | DOID:8398 (biomarker_via_orthology) | |
| Disease | HIV-1 infection, Susceptibility to viral and mycobacterial infections | 3.44e-03 | 21 | 123 | 2 | EFO_0000180, Orphanet_391311 | |
| Disease | periodontitis (biomarker_via_orthology) | 3.44e-03 | 21 | 123 | 2 | DOID:824 (biomarker_via_orthology) | |
| Disease | upper aerodigestive tract neoplasm | 3.76e-03 | 246 | 123 | 5 | EFO_0004284 | |
| Disease | idiopathic pulmonary fibrosis (is_marker_for) | 4.12e-03 | 23 | 123 | 2 | DOID:0050156 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LVETGFHHVGHAGLE | 41 | Q8N976 | |
| FHHVGHAGLELLTSS | 46 | Q8N976 | |
| HHSQLQGAHGDAVIL | 301 | O43488 | |
| LVETGFHHVAHAGLE | 371 | Q6UX73 | |
| HLTKHENFHGGLDAI | 3016 | Q9NR09 | |
| VSHITFAHEVGHNFG | 376 | O14672 | |
| IAHELGHSLGLDHDL | 346 | Q13444 | |
| GLHAAFTVAHEIGHL | 401 | Q9UNA0 | |
| FTVAHEIGHLLGLSH | 406 | Q9UNA0 | |
| HDLELGHTHGTLATA | 256 | Q8IU99 | |
| SLIHGFTCHDHGATV | 2891 | Q8TDJ6 | |
| LTGHGLIHSFKSEHA | 2971 | Q8TDJ6 | |
| FGPEHAQVLSGHLLH | 1481 | Q9Y485 | |
| AGHHHIVKFLLDFGV | 931 | Q96KQ4 | |
| GTLLFHIHHQDGAPS | 116 | O14525 | |
| AHELGHSFGIQHDGK | 391 | P58397 | |
| TIAHEIGHSFGLEHD | 221 | Q76LX8 | |
| VAHELGHSFGIQHDG | 386 | Q9UKP4 | |
| FEHHGHICIVFELLG | 231 | P49759 | |
| VAVHELGHALGLEHS | 236 | P50281 | |
| AHEFGHSLGLAHSSD | 216 | P22894 | |
| HLIGEHHDGVSKANF | 71 | P43631 | |
| AGLHVLLFGLAASAH | 246 | Q96PH1 | |
| GHHELVALLLQHGAS | 821 | Q96NW4 | |
| AHELGHSLGLFHSAN | 216 | P09238 | |
| DGHIHRLFIHGVILA | 1501 | O75147 | |
| ETHLGVNHLGHFLLT | 141 | Q96NR8 | |
| VHELGHALGLEHSSD | 281 | Q9Y5R2 | |
| AVHEFGHALGLGHSS | 231 | Q9NPA2 | |
| HEFGHALGLDHSSVP | 401 | P14780 | |
| HLIGEHHDGVSKANF | 71 | P43627 | |
| HLIGEHHDGVSKANF | 71 | P43632 | |
| GTVHPHLAAAAAAAH | 1081 | Q9H2X6 | |
| MGLDLLVFAHDHVGH | 66 | Q99685 | |
| LVFAHDHVGHGQSEG | 71 | Q99685 | |
| SDFVIHGIIHGVTHD | 186 | Q9UJH8 | |
| HLIGEHHDGVSKANF | 71 | P43628 | |
| SNVHVIGHSLGAHAA | 161 | P16233 | |
| SVRFDSIGGLSHHIH | 396 | Q9ULI0 | |
| VAVHELGHALGLEHS | 256 | P51511 | |
| AAHEIGHSLGLFHSA | 216 | P08254 | |
| HLIGHSLGAHVAGEA | 166 | P54315 | |
| AHEFGHSLGLDHSKD | 221 | P45452 | |
| LHGSSILERHHLEFG | 621 | P16499 | |
| GLHGGFAHVIEDQHK | 826 | Q2TBE0 | |
| GFHARLVHQGAAHAG | 111 | Q03052 | |
| GLHHALHEDGHEAQL | 186 | Q03052 | |
| GHAHAGGLHAAAAHL | 216 | Q03052 | |
| HLGADAGLHAALHAT | 251 | P52848 | |
| HVHLIGYSLGAHVSG | 161 | P11150 | |
| HAVHFLNESGVLLHF | 1571 | Q5S007 | |
| AVEHGAHGLETDIHL | 221 | Q6W3E5 | |
| ALRAEHHGLAGHLAE | 36 | Q6P597 | |
| HHGLAGHLAEALAGQ | 41 | Q6P597 | |
| AAAGSHLLFVLHGLE | 231 | Q86UT6 | |
| HGPFHELTVHEAACA | 176 | Q6ZMK1 | |
| AQIHDFVLGGGLHSH | 331 | P48741 | |
| LAHLASGLGHCHHLE | 1511 | Q86WI3 | |
| GLALAFHDGSVHIVH | 381 | Q9Y2X0 | |
| DIVGHGHQIFHAFLS | 276 | Q8TEZ7 | |
| ALVDHIQFGDCHIGH | 3651 | Q4G0P3 | |
| HHHYEGAVVILDAGA | 21 | P49915 | |
| IHHGRDVGVFTFDHG | 451 | Q86XK2 | |
| LHGYQLHVDLHSGGV | 351 | Q8NCQ5 | |
| EVGVKAHHLIGAGHS | 746 | Q9BYX4 | |
| GFDLVGHEDTGHSLH | 321 | Q9NZK5 | |
| LLHGCIHAIGVHLFV | 286 | O60503 | |
| FGHVSVAHLLLDHGA | 121 | Q68DC2 | |
| AGAFVDHHHPSGEQL | 166 | Q68DC2 | |
| QFGHTFGHLTHDALG | 251 | A8MTA8 | |
| GESHAHSHVLVDSLG | 696 | A4D0S4 | |
| VHEDLEIGAHHLGFL | 276 | O75881 | |
| HHHALLLLGTVAGIF | 1301 | Q9H583 | |
| LHHRGFGVACHLGVL | 131 | Q8N8Q3 | |
| HHGHVCIVFELLGLS | 231 | Q9HAZ1 | |
| GTTGAHHHAQLIFVF | 146 | Q96MD7 | |
| GFLTLVDLHHHALLA | 136 | Q14CX5 | |
| SLEDVHVIGHSLGAH | 161 | P54317 | |
| HVIGHSLGAHTAAEA | 166 | P54317 | |
| AAHAFHGLTAFHLLD | 316 | Q6UY18 | |
| VVAHIGLVEHHLFAL | 601 | Q12923 | |
| HEFGHALGLAHSTDP | 226 | O60882 | |
| HIHQDSFPHGLGLSI | 26 | P19526 | |
| NDVCVHFHELHLGLG | 46 | Q9HBJ0 | |
| LHIVQLSGGSFKHLH | 461 | Q969X6 | |
| IHSGGIDLAFPHHEN | 271 | Q9HA77 | |
| DGSHIKGLLINFIHH | 566 | Q02880 | |
| NFLAHGVLPDSGHLH | 211 | Q9Y285 | |
| HIIGGSDLIAHHARK | 701 | O60934 | |
| FDHHGAGIFKTHVLL | 386 | Q96DL1 | |
| AVHEFGHAIGLSHVA | 246 | Q9ULZ9 | |
| GHAIGLSHVAAAHSI | 251 | Q9ULZ9 | |
| NLHRVAAHELGHSLG | 211 | P03956 | |
| ALHHCFDGPTGELAH | 156 | O75900 | |
| SLHVGHLLALLGLFH | 86 | Q9Y2Z4 | |
| ALSHGQLHVEHDGES | 16 | P29622 | |
| HAPLDHGATLLHVAA | 226 | Q96I34 | |
| AITHGALHGLAYLHS | 126 | Q9H2K8 | |
| KIVHFSVGHDGSHAL | 581 | O75592 | |
| DLGHVALSLVHAGAL | 176 | Q9BVR0 | |
| GNLHLHEDAHAGIGL | 111 | Q8NA69 | |
| HEDAHAGIGLSNAHA | 116 | Q8NA69 | |
| IKGLTEGLHGFHVHE | 36 | P00441 | |
| GHEIAHAVLGHAAEK | 326 | Q96E52 | |
| HSEGLNHDFLFHGSI | 186 | Q9H1P3 | |
| LHVHRNSAHSAGVGA | 401 | P28702 | |
| LVTTHELGHNFGAEH | 401 | P78536 | |
| TLAFGIGMHHAGLHE | 1611 | Q8N3C0 | |
| GERGHFGVQILHHFI | 156 | Q8N8G6 | |
| AALLHHFHVEPAGGS | 436 | O95398 | |
| HAHGLQELEFIRGHS | 111 | Q9Y4E5 | |
| LFAVINHHGTLESGH | 651 | Q70EK9 | |
| AVFVSHLHADHHTGL | 541 | Q9BQ52 | |
| GQHFACTDSHGHLLI | 526 | Q8WWQ0 | |
| LVQGFLHSFHGGHIH | 106 | Q9H310 | |
| LHGEHAVVHGKVALA | 16 | Q03426 | |
| HLLVTGFASGIFHLH | 301 | Q15269 | |
| EGDHVFRAVHLHSGE | 71 | Q92519 | |
| HFHHGGLDKLSDVFQ | 336 | Q8TBP0 | |
| GHLVSEGVLLFGHQH | 2401 | Q6ZS81 | |
| TSVLHLGHVDHLVAG | 76 | Q71RG4 | |
| LHAVLVHEGQANAGH | 586 | Q96RU2 | |
| FFLHLLGIDTNGHAH | 206 | O95427 | |
| HSLFNGALDQAHGHV | 176 | Q8NEW0 | |
| LGDILHVADHQGTHH | 101 | E7ETH6 | |
| SHFGNLKVHERIHTG | 526 | Q9H7R0 | |
| HGASFHGHLLTLNVT | 951 | Q9UPU5 | |
| LVGVIVHSGQAHAGH | 1956 | Q9UPU5 | |
| SFHHGLGHSLLAGLH | 1081 | Q9NPG3 | |
| LGDILHLADHQGTHH | 91 | Q8TF45 | |
| GKGFHHSLDFDIHCV | 376 | A6NK53 | |
| VLIAHFLGVDHCGHK | 226 | Q8TEQ8 | |
| EAARTVAHHGGLYHT | 781 | Q8N5H7 | |
| VNVLGLCLFHHHSGF | 126 | Q9Y6M5 | |
| HLGDAAHLQAEIHTG | 191 | P21754 | |
| TGTLHRQASHHIGEF | 71 | Q5VIY5 | |
| LHGGDSHSVLYTLHH | 436 | Q68DK2 | |
| TAKSHGRINHVFGHL | 136 | Q8WVP5 | |
| LGDILHVADHQGTHH | 101 | B7Z6K7 | |
| AIGVGSFARHHHHSA | 11 | O95409 | |
| LVSELLFHEHGHLAG | 76 | Q8NCA9 | |
| SFANKHGRHVIGHID | 2171 | Q5VU43 |